跳转至内容
Merck
CN

L6645

Lacto-N-difucohexaose II

from human milk, ~95%

别名:

β-D-Gal-(1→3)-[α-L-Fuc-(1→4)]-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-[α-L-Fuc-(1→3)]-D-Glc, LNH

登录 查看组织和合同定价。

选择尺寸

关于此项目

经验公式（希尔记法）:
C38H65NO29
化学文摘社编号:
62258-12-2
分子量:
999.91
PubChem Substance ID:
24896441
UNSPSC Code:
12352201
Beilstein/REAXYS Number:
1340391
MDL number:
MFCD00133444

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

Lacto-N-difucohexaose II, from human milk, ~95%

SMILES string

C[C@@H]1O[C@@H](O[C@H]([C@@H](O)C=O)[C@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]4O)[C@H](O[C@@H]5O[C@H](CO)[C@H](O)[C@H](O)[C@H]5O)[C@H]3NC(C)=O)[C@H]2O)[C@H](O)CO)[C@@H](O)[C@H](O)[C@@H]1O

InChI key

QNSWVQWPVUZACH-GFBQVKCGSA-N

InChI

1S/C38H65NO29/c1-9-18(48)22(52)25(55)35(59-9)64-29(12(46)4-40)30(13(47)5-41)65-38-28(58)33(21(51)15(7-43)62-38)68-34-17(39-11(3)45)32(67-37-27(57)24(54)20(50)14(6-42)61-37)31(16(8-44)63-34)66-36-26(56)23(53)19(49)10(2)60-36/h4,9-10,12-38,41-44,46-58H,5-8H2,1-3H3,(H,39,45)/t9-,10-,12-,13+,14+,15+,16+,17+,18+,19+,20-,21-,22+,23+,24-,25-,26-,27+,28+,29+,30+,31+,32+,33?,34-,35-,36-,37-,38-/m0/s1

biological source

human milk

assay

~95%

storage temp.

2-8°C

正在寻找类似产品? 访问 产品对比指南

Other Notes

Lewis-a trisaccharide linked to 3-fucosyllactose

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
062H3924
062H39242
062H39241

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

M T Cancilla et al.
Analytical chemistry, 71(15), 3206-3218 (1999-08-18)
A method is described to obtain multicollision dissociation threshold (MCDT) values. These values provide relative reaction thresholds for dissociation in the three major gas-phase fragmentation reactions of oligosaccharides complexed to alkali metal ions. The quasimolecular ions are produced using matrix-assisted
Xi Huang et al.
Xenobiotica; the fate of foreign compounds in biological systems, 49(6), 708-717 (2018-10-06)
1. The pharmacokinetics (PKs) analysis of compounds absorbed after the oral administration of Si-Ni-San (SNS) decoction to functional dyspepsia (FD) patients was designed to detect whether the effects were similar to prokinetics administered to healthy rats, without ethical limitation. 2.
A S Donald et al.
Carbohydrate research, 178, 79-91 (1988-07-15)
Lacto-N-neo-difucohexaose II, beta-D-Galp-(1----4)-[alpha-L-Fucp-(1----3)]-beta-D-Glcp-NAc-(1----3)-beta-D-Galp-(1----4)-[alpha-L-Fucp-(1----3)]-D-Glc, and 3'-galactosyllactose, beta-D-Galp-(1----3)-beta-D-Galp-(1----4)-D-Glc, were isolated for the first time from human milk by means of a recycling chromatography technique. Through this method, carried out mainly on columns of K+ ion-exchange resins and either Bio-Gel P-4 or TSK
Structural and conformational studies of carbohydrate oncodevelopmental antigens.
E F Hounsell
Annales de l'Institut Pasteur. Immunology, 138(6), 863-867 (1987-11-01)
Erinn M Quinn et al.
Foods (Basel, Switzerland), 9(3) (2020-03-21)
Bifidobacteria are known to inhibit, compete with and displace the adhesion of pathogens to human intestinal cells. Previously, we demonstrated that goat milk oligosaccharides (GMO) increased the attachment of Bifidobacterium longum subsp. infantis ATCC 15697 to intestinal cells in vitro.
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持